Seek NHLBI guidance while writing your Bridge
and Small Market Applications
Apply for up to $3M to
support continued development of your Phase II SBIR or STTR-funded heart, lung,
blood, or sleep technology requiring approval or clearance by a Federal
regulatory agency. The National Heart, Lung, and Blood Institute (NHLBI) SBIR Phase IIB Bridge
and Small Market Awards programs aim to de-risk your technology and encourage partnerships
between small businesses and investors and strategic partners.
Applications due June 19, 2017.
For more information, please read the full Notice:
Thursday, June 29, 2017 at 2:00PM to 3:30PM ET
REGISTER TODAY HERE
2017 NIH Small Business Innovation Research (SBIR: PA-17-302 ) and Small Business Technology Transfer (STTR: PA-17-303) Omnibus funding opportunities are now available. The deadline is 3 months away on September 5, 2017. Learn more in NOT-OD-17-070.
Planning to submit a new
or resubmission application to NIH? We have updated our application guide and supplemental
instructions. In addition to incorporating policy changes summarized in NOT-OD-17-035, the updated (FORMS-D) application guide has been restructured and streamlined. Updates to form
instructions are listed at: Significant Changes. Learn more in NOT-OD-16-129.
It’s not too early to make sure you have all your required registrations (SAM must be renewed annually) and see if ASSIST electronic submission option is right for you
(it makes collaboration and submission easier Getting
Started: Step-by-Step).
Below are some tips to ensuring you
are ready to apply.
Get Ready
Additionally, NIH encourages investigators to use interim research products, such as preprints, to speed the dissemination and enhance the rigor of their work. Notice NOT-OD-17-050 clarifies reporting instructions to allow investigators to cite their interim research products and claim them as products of NIH funding.
Interim Research Products are complete, public research products that are not final.
For more information read the full Notice NOT-OD-17-050
Contact us at NHLBI Small Biz Inquiry form for advice and assistance.
Applications due by Friday, June 30, 2017 at 5:00PM ET
The administrative supplement is to provide support for NIH-funded investigators to participate in an entrepreneurship training course, the Concept to Clinic: Commercializing Innovation (C3i) Program. The C3i Program is designed to provide medical device innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic).
Through this program, the NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring provided by the C3i Program are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.
For more information about the program before applying, please read the full Funding Opportunity Announcement PA-17-286 and contact:
Kurt Marek, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7943
Email: kurt.marek@nih.gov
Applications Due June 26, 2017
NHLBI small business awardees are eligible to apply for a competing revision to your current award. The Regenerative Medicine Innovation Project (RMIP), will support revision projects that propose solutions to widely recognized issues in the development of safe and effective regenerative medicine therapies.
Awards are anticipated in FY 2017
To learn more about this opportunity, please read the full announcement RFA-HL-17-023 R43/R44 (SBIR) or RFA-HL-17-024 R41/R42 (STTR).
Thursday, June 15, 12:00PM - 3:00PM ET
Risk
Evaluation and Mitigation Strategies (REMS): A Deeper Dive
This webinar will introduce two topics; Risk Evaluation and
Mitigation Strategies (REMS) - Purpose, Process, and Challenges, and REMS in
Structured Product Labeling Format: An Introduction
Monday, June 19 - 1:00PM - 2:30PM ET
The
Ins and Outs of Presenting Clinical Pharmacology Information in Prescription
Drug Labeling
This presentation will include highlights from the FDA guidance,
Clinical Pharmacology Section of Labeling for Human Prescription Drug and
Biological Products—Content and Format, and key prescription drug labeling
regulations.
06/19 – 06/22 – BIO 2017 - San Diego, CA
Attending BIO?
Join NIH's Twitter Chat to find out when and where to meet NIH program staff
and how too get the most out of your BIO experience
- Date:
Wednesday, June 14, 2017 2:10PM – 3:00PM PT
- Hashtag:
#SBIRchat
07/24 - 7/27 - Stem
Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases – Burlington, VT
09/7 - NIH BEST Practices
Workshop – Orlando, FL
09/13
– 9/15 - SSTI'S 2017 ANNUAL CONFERENCE - Washington, DC
9/25 – 9/27 - The MedTech
Conference 2017 (AdvaMed) - San Jose, CA
10/3 – 10/5 - SBIR/STTR
Innovation Summit – Tampa, FL
10/31 - 2017 National
Innovation Conference - New York, NY
11/1 – 11/2 - Life Sciences Summit - New York, NY
|
